We launched Neostem, a therapy for dogs based on canine mesenchymal stem cells (MSC), developed from more than 15 years of research and 7 years of proven therapeutic application.
At Ourofino, reimagining animal health goes far beyond a purpose written on paper. It becomes concrete when we lead the evolution and sustainable growth of the animal ecosystem, placing products on the market that guarantee the health, well-being and longevity of companion animals.
Brazil has the third highest proportion of pets per population in the world. According to data released by the Abinpet report in 2022, the dog population in Brazil is 58.1 million and the cat population is 27.1 million, with growth of 3.9% and 5.9%, respectively, in compared to the previous year.
Added to the increase in population, the trend towards humanization of pets is significant. Over the years, dogs and cats have gone from pets to companion animals, being seen as members of the family, and even treated as children.
Following our purpose of Reimagining Animal Health, we launched Neostem, a therapy for dogs based on canine mesenchymal stem cells (CTM), developed from more than 15 years of research and 7 years of therapeutic application, with indication for Osteoarthritis , Keratoconjunctivitis sicca and neurological sequelae of distemper. These are illnesses that are difficult to treat, which limit the pet's routine and require a series of medications. The use of this therapy reflects on the quality of life of dogs and their owners. The reports from people who treated their pets with this technology are incredible!
English 
Portuguese 
Spanish 
Chinese 
